The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies’ segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page report you will receive 98 tables and 63 figures– all unavailable elsewhere.
The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Precision Medicine Market forecasts from 2019-2029
• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology: – Companion Diagnostics – Biomarker-based Test – Targeted Therapeutics – Pharmacogenomics – Molecular Diagnostics
The report discusses key trends, developments and participants.
• This report breaks down the precision medicine market forecast to 2029 by end-users: – Pharmaceuticals & Biotechnology Companies – Diagnostic Companies – Healthcare IT/Big Data Companies – Clinical Laboratories
The report discusses key trends, developments and participants.
• This report also breaks down the precision medicine market forecast to 2029 by therapeutic application: – Cancer – Cardiovascular Diseases – Central Nervous System – Infectious Diseases – Immunology – Others
The report discusses key trends, developments and participants.
• This study provides precision medicine market forecasts to 2029 for these regional markets: – North America: US & Canada – Europe: Germany, UK, France, Italy, Spain, Rest of Europe – Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific – Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa – Latin America: Brazil, Mexico, Rest of Latin America
For each regional market, the report discusses key trends, developments and participants.
• This report profiles selected leading companies that are the main players in the global precision medicine market: – Abbott – Danaher Corporation – GE Healthcare – GlaxoSmithKline – Illumina, Inc. – Johnson & Johnson – Laboratory Corporation of America Holdings – Novartis – Pfizer – QIAGEN – Thermo Fisher Scientific, Inc.
• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.
• This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis
• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.
Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.
Buy our report today Global Precision Medicine Market Forecast 2019-2029: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview 1.1 Global Precision Medicine Market Overview 1.1.1 Precision Medicine Market – Segmentation by Technology 1.1.2 Precision Medicine Market – Segmentation by End Users 1.1.3 Precision Medicine Market – Segmentation by Therapeutic Application 1.1.4 Precision Medicine Market – Segmentation by Geography 1.2 Why You Should Read This Report 1.3 How This Report Delivers 1.4 Key Questions Answered by This Analytical Report Include 1.5 Who is This Report For? 1.6 Methodology 1.6.1 Primary Research 1.6.2 Secondary Research 1.6.3 Market Evaluation & Forecasting Methodology 1.7 Frequently Asked Questions (FAQ) 1.8 Associated Visiongain Reports 1.9 About Visiongain
2. Introduction to Precision Medicine 2.1 Evolution and Brief History of Precision Medicine 2.2 Key Benefits of Precision Medicine 2.3 Precision Medicine: Key Areas of Application 2.4 Precision Medicine: Key Elements 2.5 Precision Medicine: Different Type of Data Used by Big Data Companies 2.6 Precision Medicine: Area of Interest
3. Global Precision Medicine Market 2019-2029 3.1 Global Precision Medicine Market by End-Users, 2019-2029 3.2 Global Precision Medicine Market by Technology, 2019-2029 3.3 Global Precision Medicine Market by Therapeutic Application, 2019-2029 3.4 Global Precision Medicine Market by Geography, 2019-2029
4. Market Dynamics 4.1 Global Precision Medicine Market Drivers 4.1.1 Upcoming Technologies in Healthcare 4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies 4.1.3 Greater Involvement in Personal Healthcare 4.1.4 A Rise in Genetic Diseases 4.1.5 Growing Demand for Targeted Therapies 4.2 Global Precision Medicine Market Restraints 4.2.1 Limitations in Application due to Lack of Research and Evidences 4.2.2 Stringent Regulatory Framework and Reimbursement Policies 4.2.3 Stringent Regulations and Standards 4.2.4 Higher Cost of Diagnostics 4.2.5 Risk to Personal Data 4.2.6 Risk of failure of Software or Hardware 4.2.7 Lack of Knowledge and Awareness 4.3 Global Precision Medicine Market Opportunities 4.3.1 Increasing Awareness in Developing Economies 4.3.2 Reduction in the cost of Genome Sequencing 4.4 Regulatory Bodies 4.4.1 Food and Drug Administration (FDA) 4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA) 4.4.3 Therapeutic Goods Administration (TGA)-Australia 4.4.4 Conformité Européenne (CE) 4.5 Consortiums 4.6 Alliances/Associations
5. Global Precision Medicine Market Forecast 2019-2029 - Segmented by End-Users 5.1 Introduction 5.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by End-Users 5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2019-2029 5.2.1 Key Market Trends, Developments and Participants 5.2.1.1 Market Trends 5.2.1.2 Market Developments 5.2.1.3 Key Participants 5.3 Global Diagnostic Tools Companies Submarket Forecast 2019-2029 5.3.1 Key Market Trends, Developments and Participants 5.3.1.1 Market Trends 5.3.1.2 Market Developments 5.3.1.3 Key Participants 5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2019-2029 5.4.1 Key Market Trends, Developments and Participants 5.4.1.1 Market Trends 5.4.1.2 Market Developments 5.4.1.3 Key Participants 5.5 Global Clinical Laboratories Submarket Forecast 2019-2029 5.5.1 Key Market Trends, Developments and Participants 5.5.1.1 Regulatory bodies and compliances 5.5.1.2 Market Trends 5.5.1.3 Key Participants
6. Global Precision Medicine Market Forecast 2019-2029 - Segmented by Technology 6.1 Introduction 6.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Technology 6.2 Global Companion Diagnostics Submarket Forecast 2019-2029 6.3 Global Biomarkers Submarket Forecast 2019-2029 6.3.1 Role of Biobanking in Biomarker 6.3.2 Key Participants 6.4 Global Biobanking in Targeted Therapeutics Submarket Forecast 2019-2029 6.4.1 Key Participants 6.5 Global Pharmacogenomics Submarket Forecast 2019-2029 6.5.1 Key Market Trends, Developments and Participants 6.5.1.1 Market Trends 6.5.1.2 Market Developments 6.5.1.3 Key Participants 6.6 Global Molecular Diagnostics Submarket Forecast 2019-2029
7. Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application 7.1 Introduction 7.1.1 Global Precision Medicine Market Forecast 2019-2029: Segmented by Therapeutic Application 7.2 Global Cancer Submarket Forecast 2019-2029 7.2.1 Types of Cancer 7.2.2 Key Market Trends, Developments & Participants 7.2.2.1 Market Trends 7.2.2.2 Market Developments 7.2.2.3 Key Participants 7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2019-2029 7.3.1 Drugs & Tests 7.3.2 Market Trends & Market Developments 7.3.2.1 Market Trends 7.3.2.2 Market Developments 7.3.2.3 Key Participants 7.4 Global Central Nervous System (CNS) Market Forecast 2019-2029 7.4.1 Neurological 7.4.1.1 Neurological Drugs & Tests 7.4.2 Psychiatric Disorders 7.4.2.1 Psychiatric Disorder Drugs & Tests 7.4.3 Market Trends & Market Developments 7.4.3.1 Market Trends 7.4.3.2 Key Participants 7.5 Global Infectious Diseases Submarket Forecast 2019-2029 7.5.1 Infectious Diseases Drugs & Tests 7.5.2 Market Developments & participants 7.5.2.1 Key Developments 7.5.2.2 Key Participants 7.6 Global Immunology Market Forecast 2019-2029 7.6.1 Market Trends 7.6.1.1 Market Trends 7.7 Global Other Therapeutic Application Submarket Forecast 2019-2029 7.7.1 Market Trends, Developments & Participants 7.7.1.1 Market Trends 7.7.1.2 Key Developments 7.7.1.3 Key Participants
8 Global Precision Medicine Market Forecast 2019-2029 – Segmented by Geography 8.1 Introduction 8.2 North America Precision Medicine Market Forecast 2019-2029 8.2.1 U.S. 8.2.1.2 Canada 8.2.1.3 Key Market Trends, Developments and Participants 8.2.1.3.1 Regulations and Compliances 8.2.1.3.2 Market Trends 8.2.1.3.3 Market Developments 8.2.1.4 Key Participants 8.3 Europe Precision Medicine Market Forecast 2019-2029 8.3.1 Key Market Trends, Developments and Participants 8.3.1.1 Regulations and Compliances 8.3.1.2 Market Developments 8.3.1.3 Key Participants 8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2019-2029 8.4.1 Key Market Trends, Developments and Participants 8.4.1.1 Market Developments 8.4.1.2 Key Participants 8.5 Middle East & Africa Precision Medicine Market Forecast 2019-2029 8.5.1 Key Market Developments and Participants 8.5.1.1 Market Developments 8.5.1.2 Key Participants 8.6 Latin America Precision Medicine Market Forecast 2019-2029 8.6.1 Key Market Developments and Participants 8.6.1.1 Market Developments 8.6.1.2 Key Participants 9. Market Analysis 9.1 Porter’s Five Forces Analysis 9.1.1 Bargaining Power of Suppliers 9.1.2 Bargaining Power of Buyer 9.1.3 Industry Rivalry 9.1.4 Threat of New Entrants 9.1.5 Threat of Substitutes 9.2 Value Chain Analysis 9.2.1 Device Manufacturer & Drug Producers 9.2.2 Healthcare Providers 9.2.3 Healthcare IT Or Big Data Companies 9.2.4 Regulators 9.2.5 Third Party Payers 9.2.6 Patients
10. Company Profiles 10.1 Abbott Laboratories: Overview 10.1.1 Abbott Laboratories: Products & Service 10.1.2 Abbott Laboratories: Key Developments 10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy 10.2 GE Healthcare: Overview 10.2.1 GE Healthcare: Products & Service 10.2.2 GE Healthcare: Key Developments 10.2.3 GE Healthcare: Future Outlook and Growth Strategy 10.3 GlaxoSmithKline plc: Overview 10.3.1 GlaxoSmithKline plc: Products & Service 10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy 10.4 Johnson & Johnson: Overview 10.4.1 Johnson & Johnson: Products & Service 10.4.2 Johnson & Johnson: Key Developments 10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy 10.5 Pfizer Inc.: Overview 10.5.1 Pfizer Inc.: Products & Service 10.5.2 Pfizer Inc.: Key Developments 10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy 10.6 Laboratory Corporation of America Holdings Overview 10.6.1 Laboratory Corporation of America Holdings: Products & Service 10.6.2 Laboratory Corporation of America Holdings: Key Developments 10.7 Danaher Corporation: Overview 10.7.1 Danaher Corporation: Products & Service 10.7.2 Danaher Corporation: Key Developments 10.8 QAGEN: Overview 10.8.1 QIAGEN: Products & Service 10.9 Thermo Fisher Scientific, Inc.: Overview 10.9.1 Thermo Fisher Scientific: Products & Service & Recent Developments 10.10 Illumina, Inc.: Overview 10.10.1 Illumina, Inc.: Products & Service & Recent Developments 10.11 Novartis AG: Overview 10.11.1 Novartis AG: Recent Developments
Appendices Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain Report Evaluation Form
List of Tables Table 2.1 Key Benefits of Precision Medicine Table 2.2 Key Elements of Precision Medicine Table 4.1 Key Benefits of Precision Medicine for Patients Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry Table 4.3 Key Consortiums in the Precision Medicine Industry Table 4.4 Key Alliances/Associations in the Precision Medicine Industry Table 5.1 Global Precision Medicine Market Forecast by End-Users: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 5.2 Global Pharma & Biotech Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 5.3 Key Developments in Pharma & Biotech Companies Table 5.4 Global Diagnostic Tool Companies End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 5.5 Key Developments in Diagnostic Companies Table 5.6 Global Healthcare ITs/Big Data End User Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 5.7 Key Developments in Healthcare IT/Big Data Companies Table 5.8 Global Clinical Laboratories Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.1 Global Precision Medicine Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.2 Global Companion Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.3 List of Approved Companion Diagnostic Devices Table 6.4 Global Biomarkers Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.5 List of Biobanks Table 6.6 Examples of Biobanking Initiatives Across Selected OECD Countries Table 6.7 Global Biobanking in Targeted Therapeutics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.8 Global Pharmacogenomics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.9 Market Developments Table 6.10 Global Molecular Diagnostics Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 6.11 Some Examples of Human Genetic Tests That Have Been Approved by the FDA Table 6.12 Some Examples of Microbial Tests That Have Been Approved by the FDA Table 7.1 Global Precision Medicine Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 7.2 Global Cancer Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 7.3 Precision Medicine Drugs and Relevant Genes: Oncology Table 7.4 Precision Medicine Genetic Tests with Respect to Oncology Table 7.5 Key Developments Table 7.6 Global Cardiovascular Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 7.7 Precision Medicine Drugs and Relevant Genes: Cardiovascular Table 7.8 Precision Medicine Genetic Tests with Respect to Cardiovascular Table 7.9 Key Developments Table 7.10 Global CNS Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029 Table 7.11 Precision Medicine Drugs and Relevant Genes: Neurology Table 7.12 Precision Medicine Drugs and Relevant Genes: Psychiatric Disorders Table 7.13 Precision Medicine Genetic Tests with Respect to Psychiatric Disorders Table 7.14 Psychiatric Disorders: Key Developments Table 7.15 Global Infectious Disease Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029 Table 7.16 Precision Medicine Drugs and Relevant Genes: Infectious Diseases Table 7.17 Key Developments Table 7.18 Global Immunology Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029 Table 7.19 Global Other Therapeutic Application Market: Revenue ($bn), AGR (%), CAGR (%) 2018-2029 Table 7.20 Precision Medicine Drugs and Relevant Genes: Other Diseases Table 7.21 Precision Medicine Genetic Tests with Respect to Other Diseases Table 7.22 Key Developments Table 8.1 Global Precision Medicine Market by Geography: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 8.2 North America Precision Medicine Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 8.3 Market Developments Table 8.4 Europe Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 8.5 Market Developments Table 8.6 APAC Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 8.7 Market Developments Table 8.8 Middle East & Africa Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 8.9 Market Developments Table 8.10 Latin America Precision Medicine Market by Countries: Revenue ($bn), AGR (%), CAGR (%), 2018-2029 Table 8.11 Market Developments Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers Table 9.2 Key Factors Affecting the Bargaining Power of Buyer Table 9.3 Key Factors Affecting the Industry Rivalry Table 9.4 Key Factors Affecting the Threat of New Entrants Table 9.5 Key Factors Affecting the Threat of Substitutes Table 10.1 Abbott Laboratories: Overview Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income ($ Mn) Table 10.3 Abbott Laboratories: Key Developments Table 10.4 GE Healthcare Overview Table 10.5 GE Healthcare: 5-year Revenue, Profit ($ Mn) Table 10.6 GE Healthcare: Key Developments Table 10.7 GlaxoSmithKline plc: Overview Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax ($ Mn) Table 10.9 Johnson & Johnson: Overview Table 10.10 Johnson & Johnson: 5-year Revenue, Net Earnings ($ Mn) Table 10.11 Johnson & Johnson: Key Developments Table 10.12 Pfizer Inc. Overview Table 10.13 Pfizer Inc.: 5-year Revenue ($ Mn) Table 10.14 Pfizer Inc: Key Developments Table 10.15 Laboratory Corporation of America Holdings: Overview Table 10.16 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income ($ Mn) Table 10.17 Laboratory Corporation: Key Developments Table 10.18 Danaher Corporation: Overview Table 10.19 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit ($ Mn) Table 10.20 Danaher Corporation: Key Developments Table 10.21 QIAGEN: Overview Table 10.22 QIAGEN: 5-year Revenue, Net Income ($ Mn) Table 10.23 Thermo Fisher Scientific, Inc.: Overview Table 10.24 Thermo Fisher Scientific, Inc.: 5-year Revenue, Net Income, Operating Income ($ Bn) Table 10.25 Illumina, Inc.: Overview Table 10.26 Illumina, Inc.: 5-year Revenue, Net Income, Operating Income ($bn) Table 10.27 Novartis AG: Overview Table 10.28 Novartis AG: 3-year Revenue, Net Income, Operating Income ($bn) Table 11.1 Key Partnerships, Collaborations and Joint Ventures Table 11.2 Key Product Developments Table 11.3 Key Acquisitions Table 11.4 Key Expansion Table 11.5 Key Patents, Approvals and Certifications Table 11.6 Key Other Events
List of Figures Figure 1.1 Global Precision Medicine Market – Segmentation by Technology Figure 1.2 Global Precision Medicine Market – Segmentation by End Users Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application Figure 1.4 Global Precision Medicine Market - Segmentation by Geography Figure 2.1 History of Precision Medicine Figure 2.2 Key Areas of Application for Precision Medicine Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine Figure 2.4 Key Areas of Interest for Precision Medicine Figure 3.1 Global Precision Medicine Market Share by End Users: Revenue ($bn), 2018-2029 Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2018-2029 Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2018-2029 Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2019-2029 Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards Figure 4.2 FDA’s Role in Precision Medicine Figure 5.1 Global Precision Medicine Market by End Users Figure 5.2 Role of Pharmaceuticals and Biotech Companies Figure 5.3 Challenges Faced by Pharma & Biotech Companies Figure 5.4 Diagnostic Tests Benefits for Stakeholders Figure 5.5 Challenges Faced by Diagnostic Companies Figure 5.6 Benefits of Big Data Figure 5.7 Transformation of Medicine Figure 5.8 Basic Ingredients Provided by Big Data for Precision Medicine Figure 5.9 Challenges Faced by Big Data Companies Figure 5.10 OECD Recommendations on The Governance of Clinical Trials Figure 6.1 Types of Precision Medicine Sub-Market Figure 6.2 Benefits of Companion Diagnostics Figure 6.3 Function of Biomarkers Figure 6.4 Biobanks Services Figure 6.5 Development in PGx Figure 6.6 Model Systems Used in PGx Figure 6.7 Challenges of PGx Studies Figure 6.8 Type of Molecular Diagnostics Test Figure 6.9 Molecular Diagnostics: Application Figure 6.10 Molecular Diagnostics: Benefits Figure 8.1 Global Precision Medicine Market Classification by Geography Figure 8.2 Key Drivers for Precision Medicine: North America Figure 8.3 Objectives of the Precision Medicine Initiative Figure 8.4 APAC: Market Challenges Figure 9.1 Precision Medicine Market Porter’s Five Forces Analysis, 2018 Figure 9.2 Precision Medicine Market Value Chain Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2018 Figure 10.2 Abbott Laboratories: Sales by Region (%), 2018 Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017 Figure 10.4 GE Healthcare: Sales by Geography (%), 2017 Figure 10.5 GlaxoSmithKline plc: Sales by Business Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017 Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017 Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017 Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2018 Figure 10.10 Pfizer Inc.: Sales by Region (%), 2018 Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017 Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017 Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017 Figure 10.14 Danaher Corporation: Sales by Region (%), 2017 Figure 10.15 QIAGEN: Sales by Business Segment (%), 2018 Figure 10.16 QIAGEN: Sales by Region (%), 2018 Figure 10.17 Thermofisher Scientific, Inc.: Sales by Business Segment (%), 2018 Figure 10.18 Thermofisher Scientific, Inc.: Sales by Region (%), 2018 Figure 10.19 Illumina, Inc.: Sales by Business Segment (%), 2017 Figure 10.20 Illumina, Inc.: Sales by Region (%), 2017 Figure 10.21 Novartis AG: Sales by Business Segment (%), 2018 Figure 10.22 Novartis AG: Sales by Region (%), 2018 Figure 11.1 Precision Medicine Market Key Development Strategies
23andMe Abbott Abbott Molecular Inc. Abcodia ACS Biomarker Actelion Pharmaceuticals Ltd. Advanced Biological Laboratories Affymetrix, Inc. Agendia BV Alacer Corp Alberta Cancer Research Biobank Alios BioPharma, Inc. Almac Almac Diagnostics Amgen Apple Archimedes Aspen Astellas Pharma Inc. Astrazeneca plc Astute Medical Asuragen, Inc. AT&T AthenaHealth, Inc. Aurora Auspex Pharmaceuticals, Inc. Avon Longitudinal Study of Parents and Children BGI Tech Solutions Co., Ltd. BioFortis BioGene bioMerieux, Inc. Bode Technology Group, Inc. CareWell Urgent Care Caris Celera Diagnostics Cell & Co Biorepository Celtics Healthcare Cepheid CFR Pharmaceuticals Ciba-Geigy Clarient Diagnostic Services, Inc. Cognizant Cooperative Human Tissue Network COPAN Covance Inc. Cubist Pharmaceuticals Daiichi Sankyo Co. ltd. Dako Dako Denmark A/S Dell Diabeter Eagle Pharmaceuticals, Inc. Eli Lilly Estonian Genome Project Ferring Pharmaceuticals Fisher BioServices Flakka Foundation Medicine GE Healthcare Genome Medicine Genomic Health GenoSpace Gen-Probe, Inc. GlaxoSmithKline (GSK) Glooko Google Inc. Hologic, Inc. Human Tissue Resource Network HUNT Biobank IBM Idera Pharmaceuticals Inc. Illumina, Inc. Immuneering Corporation Infectio Diagnostic, Inc. Institutional Biobank of Lausanne Intel Intomics Janssen Biotech Inc. Japan Post Group Johnson & Johnson Kaiser Permanente Lab-Ally LLC Laboratory Corporation of America LG Life Technologies llumina Inc. Luminex Molecular Diagnostics Inc. Lutron Electronics Mayo Clinic Medpace Medtronic Medtronic plc Merck Modul-Bio Molecular Health Monogram Bioscience Myriad Genetic Laboratories, Inc. Nanosphere, Inc. NanoString NextWave Novartis Omnyx, LLC OncoMed Pharmaceuticals, Inc. Oncotype DX OneMedNet Corporation Oracle Healthcare Panasonic Healthcare PATH Biobank Pfizer Philips Healthcare ProMedDx Q2 Solutions Qiagen Qiagen Manchester, Ltd. Qualcomm Qualcomm Life, Inc. Quest Diagnostics Randox Laboratories Randox Toxicology Reddy Laboratories Roche Roche Molecular Systems, Inc. Royal Philips Samsung Sandoz Sanofi Aventis Sanofi Pharma Siemens Clinical Lab Siemens Healthcare Signature Diagnostics AG St. Jude Medical (SJM) Sterand Plc Syapse Sysmex Sysmex Corporation Takeda Pharmaceuticals Teva Pharmaceuticals Therascreen Topera, Inc Trofile U.K. Biobank UMass Cancer Center Tissue and Tumor Bank Ventana Medical Systems, Inc. Veropharm Vysis Zinfandel Pharmaceuticals
List of Organizations Mentioned in the Report Alberta Health Services Alberta Tumour Bank American Association for Cancer Research (AACR) American Medical Association American National Standards Institute (ANSI) American Telemedicine Association Association for Molecular Pathology Beth Israel Deaconess Medical Center (BIDMC) Biobank Japan-Riken Institute Biobanque de Picardie Biological Resources Centres Canadian Biosample Repository Canadian Federal Government Canadian Institutes of Health Research (CIHR) Cancer Research Network of the FRSQ Capital Health/Regional Tissue Bank Careggi University Hospital Central Biomaterial Bank Centre for Disease Control and Prevention (CDC) Charité-Universitätsmedizin Berlin Confederation of Cancer Biobanks Danubian Biobank Consortium Tissue Bank Drug Enforcement Agency (DEA) European Association for Cancer Research (EACR) European Diagnostics Manufacturers Association (EDMA) European Federation of Pharmaceutical Industries and Associations (EFPIA) European Medicines Agency (EMA) European Society of Human Genetics Food and Drug Administration (FDA) Genethon DNA and Cell Bank German Heart Failure Network Global Medical Technology Alliance (GMTA) Health Science Research Resources Bank/Japan Health Science Foundation Healthcare information and management systems society (HIMSS) International Human Genome Sequencing Consortium International Medical Device Regulators Forum (IMDRF) Japan National Cancer Center Brain Bank for Aging Research Japanese Collection of Research Bioresources King’s College Infectious Diseases Biobank Liverpool Tissue Bank Manitoba Breast Tumour Bank National Institutes of Health (NIH) NHS Cod Blood Bank Norwegian University of Science and Technology Office of the national coordinator for health information technology (ONC HIT) Ohio State University Ontario Cancer Research Network Organization of European Cancer Institute (OECI) Patient DNA collection at Institute of Human Genetics Heidelberg Patient-Centered Outcomes Research Institute (PCORI) Pharmaceutical and medical devices agency (PMDA) PROCURE Quebec Prostate Cancer Southwest France Tumour Bank The Brain Tumour Tissue Bank The Center for Assessment Technology and Continuous Health (CATCH) The National Center for Toxicological Research (NCTR) The National Health Services (NHS) The National Institute for Health Research (NIHR) Therapeutic Goods Administration (TGA) Triangle Global Health Consortium Tumour Bank of Provence U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank U.K. DNA Banking Network U.K. Stem Cell Bank United Kingdom Clinical Research Network (UKCRN) University Hospital of Lausanne and University of Lausanne University of Bristol University of Massachusetts Medical School University of Tartu Wireless-Life Sciences Alliance (WLSA) World Health Organisation (WHO)
Download sample pages
Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2019-2029
The Alzheimer’s Disease Therapeutics and Diagnostics Market will reach $7.93bn in 2018. The Alzheimer’s Disease Therapeutics and Diagnostics Market is...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
